فرمولاسیون نالوکسون برای ترجیح انحراف از تجویز در میان بیماران دریافت کننده مواد مخدر برای کنترل درد

Two independent cohorts of respondents who were receiving opioid medications for pain management reported a preference for noninjectable over injectable formulations of naloxone to reverse an opioid overdose. Though initial preference is only one of many factors that impacts ultimate public acceptance and uptake of a new product, these results support the additional research and development of noninjectable naloxone formulations.